The impact of selection bias on vaccine effectiveness estimates from test-negative studies

Vaccine

Volumn 36, Issue 5, 2018, Pages 751-757

  Jackson, Michael L ^a   Phillips, C Hallie ^a   Benoit, Joyce ^a   Kiniry, Erika ^a   Madziwa, Lawrence ^a   Nelson, Jennifer C ^a   Jackson, Lisa A ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

Bias (Epidemiology); Human; Influenza; Methodology; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ETHNICITY; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; INFANT; INFLUENZA; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; SCHOOL CHILD; SIMULATION; SOCIAL STATUS; YOUNG ADULT; ALGORITHM; CLINICAL STUDY; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; HEALTH SURVEY; IMMUNOLOGY; ODDS RATIO; OUTCOME ASSESSMENT; SELECTION BIAS; STATISTICS AND NUMERICAL DATA; VACCINE IMMUNOGENICITY;

ALGORITHMS; CLINICAL STUDIES AS TOPIC; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; HUMANS; IMMUNOGENICITY, VACCINE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ODDS RATIO; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; SELECTION BIAS; VACCINES;

EID: 85039417467     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.12.022     Document Type: Article

References (23)

1. Jackson, M.L., Nelson, J.C., The test-negative design for estimating influenza vaccine effectiveness. Vaccine 31 (2013), 2165–2168.
2. Broome, C.V., Facklam, R.R., Fraser, D.W., Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303 (1980), 549–552.
3. Skowronski, D.M., Gilbert, M., Tweed, S.A., Petric, M., Li, Y., Mak, A., et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004–2005. Can Commun Dis Rep 31 (2005), 181–191.
4. Kissling, E., Valenciano, M., Buchholz, U., Larrauri, A., Cohen, J.M., Nunes, B., et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill, 19, 2014.
5. Zimmerman, R.K., Nowalk, M.P., Chung, J., Jackson, M.L., Jackson, L.A., Petrie, J.G., et al. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis, 2016.
6. Sullivan, S.G., Chilver, M.B., Higgins, G., Cheng, A.C., Stocks, N.P., Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. Med J Aust 201 (2014), 109–111.
7. Ali, M., You, Y.A., Sur, D., Kanungo, S., Kim, D.R., Deen, J., et al. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design. Vaccine 34 (2016), 479–485.
8. Castilla, J., Beristain, X., Martinez-Artola, V., Navascues, A., Garcia Cenoz, M., Alvarez, N., et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 30 (2012), 539–543.
9. Sullivan, S.G., Feng, S., Cowling, B.J., Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev. Vaccines 13 (2014), 1571–1591.
10. Cowling, B.J., Nishiura, H., Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology 23 (2012), 930–931.
11. Foppa, I.M., Haber, M., Ferdinands, J.M., Shay, D.K., The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 31 (2013), 3104–3109.
12. Suzuki, M., Camacho, A., Ariyoshi, K., Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs. Epidemiol Infect 142 (2014), 2642–2646.
13. De Serres, G., Skowronski, D.M., Wu, X.W., Ambrose, C.S., The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro surveillance: bulletin Europeen sur les maladies transmissibles = Eur Commun Dis Bullet, 18, 2013.
14. Jackson, M.L., Rothman, K.J., Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine 33 (2015), 1313–1316.
15. Hernan, M.A., Hernandez-Diaz, S., Robins, J.M., A structural approach to selection bias. Epidemiology 15 (2004), 615–625.
16. Sullivan, S.G., Tchetgen Tchetgen, E.J., Cowling, B.J., Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am J Epidemiol 184 (2016), 345–353.
17. Gaglani, M., Pruszynski, J., Murthy, K., Clipper, L., Robertson, A., Reis, M., et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis 213 (2016), 1546–1556.
18. McLean, H.Q., Thompson, M.G., Sundaram, M.E., Kieke, B.A., Gaglani, M., Murthy, K., et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis 211 (2015), 1529–1540.
19. Stockwell, M.S., Reed, C., Vargas, C.Y., Camargo, S., Garretson, A.F., Alba, L.R., et al. MoSAIC: mobile surveillance for acute respiratory infections and influenza-like illness in the community. Am J Epidemiol 180 (2014), 1196–1201.
20. Ohmit, S.E., Petrie, J.G., Malosh, R.E., Cowling, B.J., Thompson, M.G., Shay, D.K., et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 56 (2013), 1363–1369.
21. Ohmit, S.E., Thompson, M.G., Petrie, J.G., Thaker, S.N., Jackson, M.L., Belongia, E.A., et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 58 (2013), 319–327.
22. Haapea, M., Veijola, J., Tanskanen, P., Jaaskelainen, E., Isohanni, M., Miettunen, J., Use of inverse probability weighting to adjust for non-participation in estimating brain volumes in schizophrenia patients. Psychiatry Res 194 (2011), 326–332.
23. Thompson, C.A., Arah, O.A., Selection bias modeling using observed data augmented with imputed record-level probabilities. Ann Epidemiol 24 (2014), 747–753.